Chlamydia pneumoniae

Last updated: November 01, 2022

Chlamydia pneumoniae

Critical Care Week 2

Critical Care Week 2

Cardiovascular system anatomy and physiology
Coronary circulation
Abnormal heart sounds
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Atrial flutter
Atrial fibrillation
Supraventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Class III antiarrhythmics: Potassium channel blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Calcium channel blockers
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Atrial septal defect
Premature atrial contraction
Atrioventricular nodal reentrant tachycardia (AVNRT)
Ventricular tachycardia
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Anatomic and physiologic dead space
Ventricular arrhythmias: Pathology review
Wolff-Parkinson-White syndrome
Long QT syndrome and Torsade de pointes
Myocarditis
Adrenergic antagonists: Alpha blockers
Ventricular fibrillation
Pericardial disease: Pathology review
Action potentials in pacemaker cells
Cardiomyopathies: Clinical
Syncope: Clinical
Premature ventricular contraction
Heart failure: Clinical
Ventricular septal defect
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Pulmonary hypertension
Acute respiratory distress syndrome
Aortic aneurysms and dissections: Clinical
Peripheral vascular disease: Clinical
Valvular heart disease: Clinical
Pericardial disease: Clinical
Pulmonary embolism
Restrictive lung diseases
Pneumothorax
Chronic obstructive pulmonary disease (COPD): Clinical
Obstructive lung diseases: Pathology review
Chronic bronchitis
Coronary artery disease: Clinical
Diffuse parenchymal lung disease: Clinical
Restrictive lung diseases: Pathology review
Lung volumes and capacities
Compliance of lungs and chest wall
Gas exchange in the lungs, blood and tissues
Anatomy of the lungs and tracheobronchial tree
Pneumonia
Acute respiratory distress syndrome: Clinical
Respiratory alkalosis
Respiratory acidosis
Respiratory system anatomy and physiology
Pneumonia: Pathology review
Pneumonia: Clinical
Klebsiella pneumoniae
Chlamydia pneumoniae
Mycoplasma pneumoniae
Streptococcus pneumoniae
Pleural effusion: Clinical
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Imaging features of COVID-19 (LifeBridge Health)
Pseudomonas aeruginosa
Adenovirus
Asthma
Rheumatic heart disease
Deep vein thrombosis and pulmonary embolism: Pathology review
Cardiac conduction velocity
Cardiac tamponade
Cor pulmonale
Idiopathic pulmonary fibrosis
Diffusion-limited and perfusion-limited gas exchange
Ventilation-perfusion ratios and V/Q mismatch
Oxygen-hemoglobin dissociation curve
Oxygen binding capacity and oxygen content
Hypoxia
Pulmonary edema
Emphysema
Respiratory distress syndrome: Pathology review
Endocarditis
Angina pectoris
Stable angina
Unstable angina
Myocardial infarction
Prinzmetal angina
Peripheral artery disease
Aortic dissection
Aneurysms
Hypotension
Pulseless electrical activity
Mitral valve disease
Heart failure
Endocarditis: Pathology review
Infective endocarditis: Clinical
Restrictive cardiomyopathy
Valvular heart disease: Pathology review
Pulmonary valve disease
Aortic dissections and aneurysms: Pathology review
Saccular aneurysm
Atherosclerosis and arteriosclerosis: Pathology review
Marfan syndrome
Peripheral artery disease: Pathology review
Metabolic acidosis
Metabolic and respiratory acidosis: Clinical
Metabolic alkalosis
Metabolic and respiratory alkalosis: Clinical
Acid-base disturbances: Pathology review
Acid-base map and compensatory mechanisms
Upper respiratory tract infection
Clinical Skills: Respiratory rate assessment
Lung cancer: Clinical
Hypertension: Clinical
Class I antiarrhythmics: Sodium channel blockers
Regulation of pulmonary blood flow
Ventilation
Clinical Skills: Mechanical ventilation - conventional ventilators
Lung cancer
Standards of care for COVID-19 patients
Coronavirus disease 19 (COVID-19)
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Zones of pulmonary blood flow
Carbon dioxide transport in blood
Clinical Skills: BiPAP and CPAP
Bundle branch block
Adrenergic antagonists: Beta blockers

Transcript

Watch video only

Content Reviewers

With Chlamydia pneumoniae, which also used to be called Chlamydophila pneumoniae in the past, Chlamydia comes from “cloak” and pneumoniae means, well, pneumonia.

So, Chlamydia pneumoniae are bacteria that hide inside host cells, particularly cells of the respiratory tract, and they cause pneumonia in humans.

Now, Chlamydia pneumoniae is classically considered Gram-negative, because it can't retain the crystal violet dye used during gram staining.

Additionally, it has an outer lipopolysaccharide membrane which all Gram-negative bacteria also have. However, other Gram-negative bacteria also have a thin peptidoglycan layer under the lipopolysaccharide membrane, whereas Chlamydia pneumoniae doesn’t.

Without it, Chlamydia can’t retain the pink safranin dye used during Gram staining, so they’re not technically Gram-negative either, which is why they’re more correctly called atypical bacteria.

To visualize them, a Giemsa stain is required, which makes them look blue or reddish blue.

Now, Chlamydia pneumoniae is non-motile and round-shaped, and is also an obligate aerobe, meaning that they depend on oxygen for survival.

Additionally, Chlamydia pneumoniae are obligate intracellular pathogens which means they are unable to generate ATP so they rely on other cells for energy.

When outside of a host cell, Chlamydia pneumoniae are metabolically inactive.

So, this means that they can’t grow on artificial mediums but rather, require a host cell for culture.

Ok now, when C. pneumoniae enters a host cell, it undergoes a life cycle that alternates between two distinct forms.

The first is the small spore-looking form called the elementary body, and it’s the infective form of this bacteria.

After the elementary body enters the host cell, it gets enclosed in a vacuole called an inclusion, where it transforms into a metabolically active, star-looking form, called the reticulate body.

The reticulate body can use the host cell resources to divide, and it does that by binary fission - which means every reticulate body splits in two identical copies of reticular bodies.

On a side note, if this sounds similar to mitosis… well, it is!

But the term binary fission is used to describe division of prokaryotic cells, which don’t have a nucleus, and therefore some steps in replication are different from mitosis.

Now, eventually, binary fission results in a huge number of reticulate bodies, which then start transitioning back to elementary bodies.

So the cell becomes too small, bursting open, and letting out a lot of elementary bodies in the surrounding fluids, where they attach to other cells to repeat the cycle over and over.

Once in the lungs, the elementary body is taken up by epithelial lung cells inside an endosome, through phagocytosis.

Inside the endosome, the elementary body transforms into a reticulate body and begins to replicate.

Key Takeaways

Chlamydia pneumonia (also known as chlamydophila pneumoniae) is a round-shaped non-motile bacteria, and an obligate intracellular pathogen because they live inside host cells to survive. Chlamydia pneumoniae is known to cause pneumonia, as its name suggests, but it has also been associated with atherosclerosis, coronary artery disease, and asthma exacerbations. The symptoms of Chlamydia pneumoniae pneumonia are usually mild fever, sore throat, and dry cough.